Venus Remedies Ltd. share price target and research reports

Name: Latest research reports of Venus Remedies Ltd. authored by Keynotes Financial Opiniery and published by - Trendlyne research reports.
Item: Venus Remedies Ltd.
Rating: 5
Author: Keynotes Financial Opiniery

Latest analyst research reports with target prices and PDF download for VENUSREM, BSE:526953 Venus Remedies Ltd.

Search Inside the pdf :

Venus Remedies Ltd.

16 Aug 2023

455.05

-2.20%

Indian Pharmaceutical company

Buy: Venus Remedies Ltd.

Keynotes Financial Opiniery

The Indian pharmaceutical and healthcare sector is anticipated to register a growth of 8-10% in FY24. Pharmaceutical businesses will continue to reassess the risk of their dependencies on global supply chains, given the resurfacing of the COVID-19 pandemic in some nations and the recent Russia-Ukraine war that has significantly impacted the operations of pharmaceutical companies globally.

Venus Remedies Ltd. is trading above all available SMAs

Is Venus Remedies Ltd. worth buying?

66 Votes:

Buy 74.24%

Sell 16.67%

Hold 9.09%